2015 to 2021 Saw Increase in Gabapentinoid Use
Authors say increase driven by off-label uses for chronic pain with lack of evidence supporting use
Older Adults Average 20.7 Total Health Care Contact Days a Year
Factors linked to more ambulatory contact days include younger age, female sex, White race, non-Hispanic ethnicity
Improvements in Acute, Subacute Low Back Pain Seen Within First Six Weeks
Based on very low-certainty evidence, individuals with persistent low back pain have minimal improvements over time
>30 Percent With Migraine Experience Migraine-Related Stigma Often
Increased migraine-related stigma linked to increased disease burden across monthly headache day categories
Recent Reduction Seen in Opioid Prescribing by Surgeons
Decreasing trend seen in 81.6 percent of U.S. counties
FDA Says Marijuana Should Be Reclassified as Less Risky Drug
Currently, cannabis is classified as a Schedule I controlled substance, a category that includes heroin and LSD
Gabapentinoids Linked to Increased Risk for Severe Exacerbation in COPD
Compared with matched nonusers, gabapentinoid users have increased risk across indications of epilepsy, neuropathic pain, other chronic pain
Medical Cannabis Use for Chronic Pain Linked to New-Onset Arrhythmia
Increased risk for new-onset arrhythmia observed; most pronounced during the first 180 days
Affordable Care Act Sees Record Number of Americans Signing Up
Latest enrollment figures mean a quarter more Americans have signed up for coverage this year compared with last year
CDC: 5.7 Percent of Adults Lacked Reliable Transportation in 2022
Lack of reliable transportation for daily living more likely for women than men, lowest among Asian non-Hispanic adults
